File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Unraveling the Mysteries of Ameloblastoma in African Population: A Comprehensive Analysis of 371 Cases from Clinical, Radiological, and Histopathological Perspectives

TitleUnraveling the Mysteries of Ameloblastoma in African Population: A Comprehensive Analysis of 371 Cases from Clinical, Radiological, and Histopathological Perspectives
Authors
KeywordsAmeloblastomas
Mandible
Mouth neoplasm
Tumour duration
Tumour size
Issue Date2025
Citation
Head and Neck Pathology, 2025, v. 19, n. 1, article no. 2 How to Cite?
AbstractObjective: To analyze the frequency, clinical, histopathological, and radiological characteristics of ameloblastoma in Nigeria over the course of two decades. Study Design: A retrospective analysis was conducted on 371 cases at a Nigerian university hospital between 2000 and 2023. Age, gender, site, histological variants, tumor size and duration were analyzed. Statistical analyses included the Shapiro–Wilk test, Mann–Whitney U test, Chi-square test, and Spearman rank correlation analysis. Results: The median patient age was 30 years (mean age 32.2), with a male-to-female ratio of 1.12:1. 54.7% of cases occurred in young adults (age range 20–39 years). Among the lesions, 11.3% were in the maxilla and 88.7% in the mandible. Patients with mandibular lesions had a median age of 29 years, while those with maxillary lesions had a statistically significantly higher median age of 37.5 years p-value = 0.001. Median tumor size was 36 cm2 for the mandible and 24 cm2 for the maxilla (significant p-value of 0.002). There was no correlation between tumor size, age, or gender. However, there was a significant correlation between tumor size and the duration of the condition. Conclusion: The study concludes that ameloblastoma is more frequent among younger individuals in Nigeria and often presents with larger tumor sizes, emphasizing the need for early detection and intervention.
Persistent Identifierhttp://hdl.handle.net/10722/355451
ISSN
2023 Impact Factor: 3.2
2023 SCImago Journal Rankings: 0.890

 

DC FieldValueLanguage
dc.contributor.authorAkinshipo, Abdul Warith-
dc.contributor.authorSivaramakrishnan, Gowri-
dc.contributor.authorEnwuchola, Joy-
dc.contributor.authorEffiom, Olajumoke-
dc.contributor.authorAdeoye, John-
dc.contributor.authorRamanathan, Anand-
dc.contributor.authorChaurasia, Akhilanand-
dc.date.accessioned2025-04-08T03:40:48Z-
dc.date.available2025-04-08T03:40:48Z-
dc.date.issued2025-
dc.identifier.citationHead and Neck Pathology, 2025, v. 19, n. 1, article no. 2-
dc.identifier.issn1936-055X-
dc.identifier.urihttp://hdl.handle.net/10722/355451-
dc.description.abstractObjective: To analyze the frequency, clinical, histopathological, and radiological characteristics of ameloblastoma in Nigeria over the course of two decades. Study Design: A retrospective analysis was conducted on 371 cases at a Nigerian university hospital between 2000 and 2023. Age, gender, site, histological variants, tumor size and duration were analyzed. Statistical analyses included the Shapiro–Wilk test, Mann–Whitney U test, Chi-square test, and Spearman rank correlation analysis. Results: The median patient age was 30 years (mean age 32.2), with a male-to-female ratio of 1.12:1. 54.7% of cases occurred in young adults (age range 20–39 years). Among the lesions, 11.3% were in the maxilla and 88.7% in the mandible. Patients with mandibular lesions had a median age of 29 years, while those with maxillary lesions had a statistically significantly higher median age of 37.5 years p-value = 0.001. Median tumor size was 36 cm2 for the mandible and 24 cm2 for the maxilla (significant p-value of 0.002). There was no correlation between tumor size, age, or gender. However, there was a significant correlation between tumor size and the duration of the condition. Conclusion: The study concludes that ameloblastoma is more frequent among younger individuals in Nigeria and often presents with larger tumor sizes, emphasizing the need for early detection and intervention.-
dc.languageeng-
dc.relation.ispartofHead and Neck Pathology-
dc.subjectAmeloblastomas-
dc.subjectMandible-
dc.subjectMouth neoplasm-
dc.subjectTumour duration-
dc.subjectTumour size-
dc.titleUnraveling the Mysteries of Ameloblastoma in African Population: A Comprehensive Analysis of 371 Cases from Clinical, Radiological, and Histopathological Perspectives-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s12105-024-01739-x-
dc.identifier.pmid39776309-
dc.identifier.scopuseid_2-s2.0-85214227983-
dc.identifier.volume19-
dc.identifier.issue1-
dc.identifier.spagearticle no. 2-
dc.identifier.epagearticle no. 2-
dc.identifier.eissn1936-0568-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats